Sterling Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Sterling Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,500	Closed	-$254K	–	989
2017 Q3	$254K	Buy	+2,500	New	+$268K	﹤0.01%	850
2017 Q2	–	Sell	-2,336	Closed	-$283K	–	1031
2017 Q1	$283K	Buy	+2,336	New	+$287K	﹤0.01%	856
2014 Q3	–	Sell	-2,381	Closed	-$255K	–	973
2014 Q2	$255K	Buy	+2,381	New	+$166K	﹤0.01%	832

Other funds holding GWPH

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Sterling Capital Management's GWPH Position: Q4 2017 in Review

Sterling Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2017, closing a stake of 2,500 shares — an estimated $254K sold.

Sterling Capital Management first reported a position in GWPH in Q2 2014 and held it in 3 quarters. The position peaked at $283K in Q1 2017. 204 funds tracked by Wall St. Rank hold GWPH as of Q4 2017.

Sterling Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
Sterling Capital Management sold 2,500 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2017, an estimated $254K.
Sterling Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 3 quarters.
Sterling Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $283K in Q1 2017.
204 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2017.

Based on Sterling Capital Management's 13F filing for Q4 2017, filed 15 Feb 2018.